CN103463517A - Medicament for treating asthma - Google Patents

Medicament for treating asthma Download PDF

Info

Publication number
CN103463517A
CN103463517A CN201310441725XA CN201310441725A CN103463517A CN 103463517 A CN103463517 A CN 103463517A CN 201310441725X A CN201310441725X A CN 201310441725XA CN 201310441725 A CN201310441725 A CN 201310441725A CN 103463517 A CN103463517 A CN 103463517A
Authority
CN
China
Prior art keywords
parts
asthma
medicament
herba
cortex
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201310441725XA
Other languages
Chinese (zh)
Other versions
CN103463517B (en
Inventor
孙凡景
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
The Fifth People's Hospital of Qidong
Original Assignee
孙凡景
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 孙凡景 filed Critical 孙凡景
Priority to CN201310441725.XA priority Critical patent/CN103463517B/en
Publication of CN103463517A publication Critical patent/CN103463517A/en
Application granted granted Critical
Publication of CN103463517B publication Critical patent/CN103463517B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)

Abstract

The invention discloses a medicament for treating asthma. The medicament is characterized by comprising the following raw medicinal materials in parts by weight: 15-20 parts of loquat leaf, 15-20 parts of aster tataricus, 10-15 parts of cortex mori, 10-15 parts of dandelion, 10-15 parts of chamomile, 10-15 parts of agastache rugosus, 5-10 parts of cortex lycii radicis, 5-10 parts of glycyrrhiza, 5-10 parts of coix seed, 1-5 parts of pearl powder, 1-5 parts of burdock, 1-5 parts of common bombax flower and 1-5 parts of sweet almond. The medicament has the effects of clearing away heat and toxic materials, clearing damp, removing stasis, moistening lungs, eliminating phlegm and stopping cough, has a good treatment effect on asthma, and can take effect quickly, and no relapse occurs.

Description

The medicine for the treatment of asthma
Technical field
The present invention relates to a kind of medicine for the treatment of asthma, be specifically related to a kind of compositions formed by Chinese medicine ingredients, belong to medical technical field.
Background technology
Asthma is a kind of commonly encountered diseases, frequently-occurring disease, and at present, global asthmatic patient is 300,000,000 people approximately, Chinese patients with asthma approximately 3,000 ten thousand.The common sympton of asthmatic patient be paroxysmally pant, the symptom such as out of breath, uncomfortable in chest or cough, small number of patients also may be take chest pain as main manifestations.The risk factor of asthma comprises host factor (inherited genetic factors) and two aspects of environmental factors.Inherited genetic factors can embody with it a lot of patients, in the middle of most patients' relatives (have relationship by blood, nearly three generations people), asthma (recurrent cough, pant) or other anaphylactic diseases (allergic rhinitis, atopic dermatitis) medical history can have been traced back to.Most of asthmatic patients belong to allergic constitution, itself may with allergic rhinitis and/atopic dermatitis, or to the allergen (acarid, pollen, house pet, mycete etc.) of common air-borne transmission, some food (nut, milk, Semen arachidis hypogaeae, seafood etc.), drug allergy etc.
Asthma is to affect the able-bodied important diseases of people, treatment not in time, lack of standardization, asthma may be fatal, therefore treatment asthma is extremely important in time.
Summary of the invention
The purpose of this invention is to provide a kind of medicine for the treatment of asthma, this medicine can be good at treating asthma, and without recurrence.
Technical solution of the present invention is as follows:
A kind of medicine for the treatment of asthma is characterized in that being grouped into by the one-tenth of following weight portion: Folium Eriobotryae 15-20 part, Radix Asteris 15-20 part, Cortex Mori 10-15 part, Herba Taraxaci 10-15 part, Flos Matricariae chamomillae 10-15 part, Herba Pogostemonis 10-15 part, Cortex Lycii 5-10 part, Radix Glycyrrhizae 5-10 part, Semen Coicis 5-10 part, Margarita powder 1-5 part, Fructus Arctii 1-5 part, Flos Bombacis Malabarici 1-5 part, Semen pruni armeniacae 1-5 part.
Preferably, when each composition adopts following consumption, effect is best: 16 parts of Folium Eriobotryaes, 16 parts of Radix Asteriss, 12 parts of Cortex Mori, 12 parts of Herba Taraxacis, 12 parts of Flos Matricariae chamomillae, 12 parts of Herba Pogostemoniss, 6 parts of Cortex Lycii, 6 parts, Radix Glycyrrhizae, 6 parts of Semen Coicis, 4 parts of Margarita powder, 4 parts of Fructus Arctiis, 4 parts of Flos Bombacis Malabaricis, 4 parts of Semen pruni armeniacaes.
The present invention, mainly by the cooperation of each medicine, plays the effect of heat-clearing and toxic substances removing, damp eliminating eliminating stagnation, moistening the lung and resolving phlegm cough-relieving, and each crude drug effect is as follows:
Folium Eriobotryae, attach to the lung and stomach meridians, and has the effect of clearing away lung-heat to relieve cough, stopping nausea and vomiting by lowering the adverse flow of QI, for the cough due to lung-heat, and QI rising in reverse order dyspnea with rapid respiration, gastropyretic vomiting, hiccup.
Radix Asteris, have the effect of nourishing the lung to keep the adverse QI downward, preventing phlegm from forming and stopping coughing, for cough, deficiency of the lung chronic cough, consumptive lung disease lung abscess, cough vomiting bloody pus, dysuria.
Cortex Mori, the root bark of moraceae plants Mulberry Morus alba L., have eliminating pathogen from the lung for relieving asthma, and the effect of inducing diuresis to remove edema, for lung-heat cough with asthma, the edema of the face, the diseases such as dysuria.
Herba Taraxaci, have the effect of heat-clearing and toxic substances removing, eliminating carbuncle eliminating stagnation, for upper respiratory tract infection, eye conjunctivitis, mumps, hyperglycemia, pharyngitis, control acute mastitis, lymphadenitis, scrofula, the furuncle carbuncle toxin, acute conjunctivitis, cold, fever, acute tonsillitis, the diseases such as acute bronchitis, urinary tract infection.
Flos Matricariae chamomillae, mildly bitter flavor, sweet perfume (or spice), there is improving eyesight, move back liver-fire, the effect of expelling phlegm for arresting cough, but Cure for insomnia, reduce blood pressure, can invigorate, refresh oneself, can effectively alleviate bronchitis and asthma, the myalgia that headache, migraine or the flu of can releiving causes, centering and gastric acid, releive neural helpful.
Herba Pogostemonis, enter lung, spleen, stomach warp, has the effect of dispelling summer-heat from superficies of the body, removing dampness to restore normal function of the stomach, for the summertime flu, and the cold and heat headache, breast gastral cavity painful abdominal mass is vexed, and vomiting is had loose bowels, vomiting during pregnancy, nasal sinusitis, hands, tinea pedis.
Cortex Lycii, have the effect of removing heat from blood except steaming, lung heat clearing pathogenic fire reducing, for deficiency of YIN hectic fever, hectic fever due to YIN-deficiency night sweat, cough due to lung-heat, spitting of blood, epistaxis.
Radix Glycyrrhizae, the function invigorating the spleen and replenishing QI, heat-clearing and toxic substances removing, expelling phlegm for arresting cough, relieving spasm to stop pain, coordinating the actions of various ingredients in a prescription, for weakness of the spleen and stomach, fatigue and weakness, shortness of breath and palpitation, cough with copious phlegm, gastral cavity abdomen, the anxious pain of extremity contraction, carbuncle sore tumefacting virus, cushion toxicity, strong.
Semen Coicis, have the effect of invigorating spleen to remove dampness, warming spleen and stomach for dispelling cold, benefiting vital QI and blood, clearing away heat and discharging pus, for cold syndrome of the stomach pain, deficient qi and blood.
Margarita powder, have the effect of the arresting convulsion of calming the nerves, improving eyesight removing nebula, removing toxic substances and promoting granulation, for the insomnia of palpitating with fear, and the infantile convulsion epilepsy, order is given birth to nebula, and skin infection is not held back.
Fructus Arctii, have the effect of dispelling wind and heat pathogens, lung qi dispersing rash, resolving toxin and disinhibiting the throat, for anemopyretic cold, and cough with copious phlegm, measles, rubella, laryngopharynx swelling and pain, the cheek erysipelas of itching, carbuncle sore tumefacting virus.
Flos Bombacis Malabarici, have the effect of heat clearing away, dampness removing, removing toxic substances, for having loose bowels, and dysentery, metrorrhagia, sore.
Semen pruni armeniacae, nature and flavor are sweet flat, have the effect of the moist dryness of the lung, relieving cough and asthma, loosening bowel to relieve constipation, and for cough due to consumptive disease, asthma, the breast abdomen is contrary vexed, dryness of the intestine constipation, constipation with dry stool.
Process for preparing medicine of the present invention is simple, and each ingredient be dry, pulverize to 80-120 purpose fine powder, and mix homogeneously can be used.
It is ingredient that Folium Eriobotryae, Radix Asteris, Cortex Mori, Herba Taraxaci, Flos Matricariae chamomillae, Herba Pogostemonis, Cortex Lycii, Radix Glycyrrhizae, Semen Coicis, Margarita powder, Fructus Arctii, Flos Bombacis Malabarici, Semen pruni armeniacae are take in the present invention, effect with heat-clearing and toxic substances removing, damp eliminating eliminating stagnation, moistening the lung and resolving phlegm cough-relieving, asthma is had to good therapeutical effect, rapid-action, without recurrence.
The specific embodiment
Below in conjunction with specific embodiment, the invention will be further described, should be understood that, following explanation is only in order to explain the present invention, its content is not limited.If following composition, without specified otherwise, is weight portion.
embodiment 1
Pharmaceutical formulation is as follows: 16 parts of Folium Eriobotryaes, 16 parts of Radix Asteriss, 12 parts of Cortex Mori, 12 parts of Herba Taraxacis, 12 parts of Flos Matricariae chamomillae, 12 parts of Herba Pogostemoniss, 6 parts of Cortex Lycii, 6 parts, Radix Glycyrrhizae, 6 parts of Semen Coicis, 4 parts of Margarita powder, 4 parts of Fructus Arctiis, 4 parts of Flos Bombacis Malabaricis, 4 parts of Semen pruni armeniacaes.
By the mentioned component mix homogeneously, be ground into 80-120 purpose fine powder, obtain asthma drug of the present invention.
embodiment 2
Pharmaceutical formulation is as follows: 15 parts of Folium Eriobotryaes, 20 parts of Radix Asteriss, 15 parts of 10 parts of Herba Taraxacis of Cortex Mori, 10 parts of Flos Matricariae chamomillae, 15 parts of Herba Pogostemoniss, 5 parts of Cortex Lycii, 10 parts, Radix Glycyrrhizae, 5 parts of Semen Coicis, 5 parts of Margarita powder, 1 part of Fructus Arctii, 5 parts of Flos Bombacis Malabaricis, 1 part of Semen pruni armeniacae.Preparation method is with embodiment 1.
embodiment 3
Pharmaceutical formulation is as follows: 20 parts of Folium Eriobotryaes, 15 parts of Radix Asteriss, 15 parts of Cortex Mori, 10 parts of Herba Taraxacis, 15 parts of Flos Matricariae chamomillae, 10 parts of Herba Pogostemoniss, 10 parts of Cortex Lycii, 5 parts, Radix Glycyrrhizae, 10 parts of Semen Coicis, 1 part of Margarita powder, 5 parts of Fructus Arctiis, 1 part of Flos Bombacis Malabarici, 5 parts of Semen pruni armeniacaes.Preparation method is with embodiment 1.
embodiment 4
Pharmaceutical formulation is as follows: 15 parts of Folium Eriobotryaes, 15 parts of Radix Asteriss, 10 parts of Cortex Mori, 10 parts of Herba Taraxacis, 10 parts of Flos Matricariae chamomillae, 10 parts of Herba Pogostemoniss, 5 parts of Cortex Lycii, 5 parts, Radix Glycyrrhizae, 5 parts of Semen Coicis, 1 part of Margarita powder, 1 part of Fructus Arctii, 1 part of Flos Bombacis Malabarici, 1 part of Semen pruni armeniacae.
embodiment 5
Tablet of the present invention, filling a prescription is: 20 parts of Folium Eriobotryaes, 20 parts of Radix Asteriss, 15 parts of Cortex Mori, 15 parts of Herba Taraxacis, 15 parts of Flos Matricariae chamomillae, 15 parts of Herba Pogostemoniss, 10 parts of Cortex Lycii, 10 parts, Radix Glycyrrhizae, 10 parts of Semen Coicis, 5 parts of Margarita powder, 5 parts of Fructus Arctiis, 5 parts of Flos Bombacis Malabaricis, 5 parts of Semen pruni armeniacaes.Preparation method is with embodiment 1.
clinical trial
1, patient source
Screen 210 routine asthmatic patients from this city hospital outpatient, patient's symptom is: during seizure of disease with cough, expectoration, pant, the symptom such as dyspnea, uncomfortable in chest and chest pain.Wherein, male's 115 examples, women's 95 examples, patient's mean age is 41.3 ± 3.6 years old, sick time 5.0 ± 2.3 years.
2, Therapeutic Method
The patient is divided into to 3 groups, every group of 70 people, between each group on sex, age, the course of disease no difference of science of statistics.When treatment, above-mentioned 3 groups of patients are used respectively to the medicine of the embodiment of the present invention 1,2,4, every day 3 times, each 6g.Use continuously after 2 weeks, observe therapeutic effect.
3, curative effect judgement
Produce effects: the Severe Asthma symptoms such as the patient is uncomfortable in chest, chest pain, dyspnea are alleviated fully, slight outbreak are arranged once in a while only with mild such as coughs, do not need medication;
Effectively: during patient's asthma attack, symptom obviously alleviates, and attack times also reduces to some extent;
Invalid: after medication, patient's symptoms of asthma is without alleviating.
4, therapeutic effect
After medication two weeks, each organizes the patient treatment situation as following table:
After patient's medication one week, symptom is well alleviated, and within severe patient medication 2-3 month, can fully recover, and the patients with mild medication can be fully recovered in one month.The recovery from illness patient pays a return visit in 1 year afterwards, all without recurrence.

Claims (2)

1. a medicine for the treatment of asthma, is characterized in that being grouped into by the one-tenth of following weight portion: Folium Eriobotryae 15-20 part, Radix Asteris 15-20 part, Cortex Mori 10-15 part, Herba Taraxaci 10-15 part, Flos Matricariae chamomillae 10-15 part, Herba Pogostemonis 10-15 part, Cortex Lycii 5-10 part, Radix Glycyrrhizae 5-10 part, Semen Coicis 5-10 part, Margarita powder 1-5 part, Fructus Arctii 1-5 part, Flos Bombacis Malabarici 1-5 part, Semen pruni armeniacae 1-5 part.
2. the medicine for the treatment of asthma according to claim 1, is characterized in that being grouped into by the one-tenth of following weight portion: 16 parts of Folium Eriobotryaes, 16 parts of Radix Asteriss, 12 parts of Cortex Mori, 12 parts of Herba Taraxacis, 12 parts of Flos Matricariae chamomillae, 12 parts of Herba Pogostemoniss, 6 parts of Cortex Lycii, 6 parts, Radix Glycyrrhizae, 6 parts of Semen Coicis, 4 parts of Margarita powder, 4 parts of Fructus Arctiis, 4 parts of Flos Bombacis Malabaricis, 4 parts of Semen pruni armeniacaes.
CN201310441725.XA 2013-09-26 2013-09-26 Medicament for treating asthma Active CN103463517B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201310441725.XA CN103463517B (en) 2013-09-26 2013-09-26 Medicament for treating asthma

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201310441725.XA CN103463517B (en) 2013-09-26 2013-09-26 Medicament for treating asthma

Publications (2)

Publication Number Publication Date
CN103463517A true CN103463517A (en) 2013-12-25
CN103463517B CN103463517B (en) 2015-05-13

Family

ID=49788709

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201310441725.XA Active CN103463517B (en) 2013-09-26 2013-09-26 Medicament for treating asthma

Country Status (1)

Country Link
CN (1) CN103463517B (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105055984A (en) * 2015-09-23 2015-11-18 青岛友诚高新技术有限公司 Traditional Chinese medicine composition for treating asthma and preparation method thereof
CN108721546A (en) * 2018-08-17 2018-11-02 刘凌华 A kind of sprayer formulation for treating asthma

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
张丽娜: "小儿咳喘五脏论治", 《吉林中医药》 *
药典委员会: "《中华人民共和国药典 2005年 一部》", 31 December 2005 *
邓琪等: "木棉花研究进展", 《今日药学》 *
郑汉臣等: "值得重视的归化药用和香料植物——母菊(洋甘菊)", 《中草药》 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105055984A (en) * 2015-09-23 2015-11-18 青岛友诚高新技术有限公司 Traditional Chinese medicine composition for treating asthma and preparation method thereof
CN108721546A (en) * 2018-08-17 2018-11-02 刘凌华 A kind of sprayer formulation for treating asthma

Also Published As

Publication number Publication date
CN103463517B (en) 2015-05-13

Similar Documents

Publication Publication Date Title
CN103405596A (en) Traditional Chinese medicine for treating sinusitis
CN102743737A (en) Chinese medicinal preparation for effectively treating tracheitis
CN103463538B (en) Asthma medicine
CN105412858A (en) Syrup and preparation method thereof
CN101041049A (en) Chinese traditional medicine compound took orally for treating chronic bronchitis
CN103463517B (en) Medicament for treating asthma
CN104721665A (en) Traditional Chinese medicine composition for treating cough and preparation method thereof
CN102178892A (en) Chinese medicinal composition for treating depression
CN104983968A (en) Pyretolysis traditional Chinese medicine composition and preparation method
CN101953958B (en) Chinese medicament for treating epidemic parotitis
CN104147194A (en) Traditional Chinese medicine composition for treating chronic sinusitis
CN103463518B (en) Medicament for relieving cough and asthma
CN105327182A (en) Medicine for treating child pertussis and preparation method thereof
CN102526236A (en) Pharmaceutical formulation for treating influenza and preparation method thereof
CN105748899A (en) Pharmaceutical preparation for treating pharyngitis and use thereof
CN103463305B (en) Traditional Chinese medicine composition for treating asthma
CN104523988A (en) Traditional Chinese medicine composition for treating asthma and preparation method thereof
CN103463537B (en) Medicament for treating infantile asthma
CN103463444B (en) Traditional Chinese medicine composition for treating phlegm stagnation cross-resistance type acnes
CN103494986B (en) The Chinese medicine for the treatment of primary trigeminal neuralgia
CN103463401B (en) Asthma medicine for infants
CN102552560A (en) Compound combination medicament for effectively treating hand-foot-and-mouth disease
CN104587055A (en) Traditional Chinese medicine composition treating asthma and preparation method thereof
CN104523987A (en) Preparation method of traditional Chinese medicine composition for treating asthma
CN104352653A (en) Medicine for treating asthma and preparation method thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
ASS Succession or assignment of patent right

Owner name: DONG QIANG

Free format text: FORMER OWNER: SUN FANJING

Effective date: 20150403

CB03 Change of inventor or designer information

Inventor after: Dong Qiang

Inventor after: Jia Guiling

Inventor after: Xu Jinjuan

Inventor before: Sun Fanjing

COR Change of bibliographic data

Free format text: CORRECT: INVENTOR; FROM: SUN FANJING TO: DONG QIANG JIA GUILING XU JINJUAN

Free format text: CORRECT: ADDRESS; FROM: 250000 JINAN, SHANDONG PROVINCE TO: 262500 WEIFANG, SHANDONG PROVINCE

TA01 Transfer of patent application right

Effective date of registration: 20150403

Address after: Chinese Medicine Hospital No. 2727 Qingzhou Hai'ao road 262500 in Shandong province Weifang city Qingzhou City

Applicant after: Dong Qiang

Address before: Ji'nan City Central Jiwei Road No. 106 of 250000 cities in Shandong Province

Applicant before: Sun Fanjing

C14 Grant of patent or utility model
GR01 Patent grant
TR01 Transfer of patent right

Effective date of registration: 20170512

Address after: 17, Jiangsu 226000, Qidong City, Nantong Hai re town

Patentee after: The Fifth People's Hospital of Qidong

Address before: Chinese Medicine Hospital No. 2727 Qingzhou Hai'ao road 262500 in Shandong province Weifang city Qingzhou City

Patentee before: Dong Qiang

TR01 Transfer of patent right